Cheplapharm to acquire Losec’s global commercial rights for $243m
German pharmaceutical company Cheplapharm Arzneimittel has signed an agreement to purchase global commercial rights for Losec (omeprazole) from AstraZeneca for…
Gastroenterology
Latest in
Gastroenterology
FDA investigating Zantac for carcinogenic chemicals
Zantac tablets have been found to contain 26,000 times the FDA-approved amount of NDMA (a cancer-causing chemical) that can be…
By
FDA to review ranitidine after detecting cancer-causing contamination
The US Food and Drug Administration (FDA) has issued a statement regarding the safety of the drug ranitidine after the…
Takeda submits NDA for SC formation of ulcerative colitis treatment
Takeda Pharmaceutical has submitted a new drug application (NDA) in Japan for a subcutaneous (SC) formulation of vedolizumab to treat…
Takeda takes a step forward in becoming dominant player in IBD landscape
The Japanese drugmaker intends to make Entyvio available in both a pre-filled syringe as well as a pen to add…
By
Will value-based pricing be a trump card for Takeda’s Alofisel?
GlobalData expects new pricing scheme will provide Takeda greater clout to negotiate with the cost-conscious authorities of the EU.
By
Risk of ulcerative colitis increases in old age for young adults with a low body mass index
Low BMI in young men was associated with an increased risk of UC in a 40-year follow-up study.
By